56239-39-5

Basic information

• Product Name: (3-BENZYLOXY-PHENYL)-HYDRAZINE
• Synonyms: (3-BENZYLOXY-PHENYL)-HYDRAZINE
• CAS NO: 56239-39-5
• Molecular Formula: C₁₃H₁₄N₂O
• Molecular Weight: 214.26306
• Mol File: 56239-39-5.mol

Chemical Properties

• Boiling Point: 393.8±25.0 °C(Predicted)
• Appearance: /
• Density: 1.185±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 5.40±0.10(Predicted)
• CAS DataBase Reference: (3-BENZYLOXY-PHENYL)-HYDRAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: (3-BENZYLOXY-PHENYL)-HYDRAZINE(56239-39-5)
• EPA Substance Registry System: (3-BENZYLOXY-PHENYL)-HYDRAZINE(56239-39-5)

Safety Data

• Hazardous Substances Data: 56239-39-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research and Development:
(3-BENZYLOXY-PHENYL)-HYDRAZINE is used as a building block for the synthesis of various organic compounds, particularly in the creation of new drugs and biologically active molecules. Its unique structure and functional groups contribute to the development of innovative pharmaceutical agents.
Used in Chemical Research:
In the field of chemical research, (3-BENZYLOXY-PHENYL)-HYDRAZINE is utilized as a reagent to introduce the hydrazine functional group into other molecules. This capability is crucial for the advancement of organic chemistry, enabling the synthesis of a wide range of chemical entities with potential applications in various industries.
Used in Organic Synthesis:
(3-BENZYLOXY-PHENYL)-HYDRAZINE is employed as a key intermediate in organic synthesis, facilitating the creation of complex organic molecules. Its presence in the synthesis process can lead to the development of novel compounds with specific properties and applications.
Used in Drug Development:
Due to its potential applications in the development of new drugs, (3-BENZYLOXY-PHENYL)-HYDRAZINE is used in drug discovery processes. Its ability to be integrated into the molecular structures of potential therapeutic agents makes it a valuable component in the quest for new treatments for various diseases and conditions.

Downstream Products

• 876300-22-0 phenyl {1-[3-(benzyloxy)phenyl]-3-tert-butyl-1H-pyrazol-5-yl}carbamate 
• 876300-20-8 phenyl (3-tert-butyl-1-{3-[2-(tetrahydro-2H-pyran-2-yloxy)ethoxy]phenyl}-1H-pyrazol-5-yl)carbamate 
• 876300-15-1 5-tert-butyl-2-{3-[2-(tetrahydro-pyran-2-yloxy)-ethoxy]-phenyl}-2H-pyrazol-3-ylamine 
• 869663-62-7 3-(5-amino-3-tert-butyl-1H-pyrazol-1-yl)phenol 
• 1344738-00-6 1-[3-tert-butyl-1-(3-hydroxyphenyl)-1H-pyrazol-5-yl]-3-[2-({3-[2-(methylsulfinyl)phenyl][1,2,4]triazolo[4,3-a]pyridin-6-yl}thio)benzyl]urea 
• 1344738-32-4 1-{1-[3-(benzyloxy)phenyl]-3-tert-butyl-1H-pyrazol-5-yl}-3-{2-[(3-{2-[(2-hydroxyethyl)thio]phenyl}[1,2,4]triazolo[4,3-a]pyridin-6-yl)thio]benzyl}urea 
• 1027538-90-4 1-{3-tert-butyl-1-[3-(2-hydroxyethoxy)phenyl]-1H-pyrazol-5-yl}-3-(2-{[3-(2-chloro-5-hydroxyphenyl)[1,2,4]triazolo[4,3-a]pyridin-6-yl]thio}benzyl)urea 
• 1344738-35-7 1-(3-tert-butyl-1-{3-[2-(tetrahydro-2H-pyran-2-yloxy)ethoxy]phenyl}-1H-pyrazol-5-yl)-3-(2-{[3-(2-chloro-5-hydroxyphenyl)[1,2,4]triazolo[4,3-a]pyridin-6-yl]thio}benzyl)urea 
• 1344738-34-6 1-(3-tert-butyl-1-{3-[2-(tetrahydro-2H-pyran-2-yloxy)ethoxy]phenyl}-1H-pyrazol-5-yl)-3-(2-{[3-(2-hydroxyphenyl)[1,2,4]triazolo[4,3-a]pyridin-6-yl]thio}benzyl)urea 
• 1344738-29-9 1-{1-[3-(benzyloxy)phenyl]-3-tert-butyl-1H-pyrazol-5-yl}-3-{2-[(3-{2-[(2-{[tert-butyl(dimethyl)silyl]oxy}ethyl)thio]phenyl}[1,2,4]triazolo[4,3-a]pyridin-6-yl)thio]benzyl}urea 
• 876300-27-5 1-{1-[3-(benzyloxy)phenyl]-3-tert-butyl-1H-pyrazol-5-yl}-3-(2-{[3-(2-hydroxyphenyl)[1,2,4]triazolo[4,3-a]pyridin-6-yl]thio}benzyl)urea 
• 1344738-33-5 1-{1-[3-(benzyloxy)phenyl]-3-tert-butyl-1H-pyrazol-5-yl}-3-{2-[(3-isopropyl[1,2,4]triazolo[4,3-a]pyridin-6-yl)thio]benzyl}urea